Article    Table of Contents                    Full Text of this article Free    Figures/Tables List  Services    Send comment/rapid response letter    Notify a friend about this article    Alert me when this article is cited    Add to Personal Archive    Download to Citation Manager    ACP Search                            Get Permissions  Google Scholar    Search for Related Content  PubMed Articles in PubMed by Author:    Jackson, L. A.    Schuchat, A.    Related Articles in PubMed    PubMed Citation    PubMed

ARTICLE

Risk Factors for Group B Streptococcal Disease in Adults

Lisa A. Jackson, MD; Roberta Hilsdon, AAS; Monica M. Farley, MD; Lee H. Harrison, MD; Arthur L. Reingold, MD; Brian D. Plikaytis, MS; Jay D. Wenger, MD; and Anne Schuchat, MD

15 September 1995 | Volume 123 Issue 6 | Pages 415-420

Objective: To determine risk factors for community-acquired and nosocomial group B streptococcal disease in adults.

Design: Case-control study.

Setting: 3 metropolitan areas in the United States with an aggregate population of 6.6 million persons.

Patients: 219 nonpregnant adults with invasive group B streptococcal infection identified by a population-based surveillance in 1991 and 1992 and 645 hospital-matched controls.

Results: The following conditions were associated with a significantly increased risk for community-acquired group B streptococcal infection after controlling for age in multivariate analysis: cirrhosis (odds ratio, 9.7 [95% CI, 3.5 to 26.9]; P < 0.001), diabetes (odds ratio, 3.0 [CI, 1.9 to 4.7]; P < 0.001), stroke (odds ratio, 3.5 [CI, 1.9 to 6.4]; P < 0.001), breast cancer (odds ratio, 4.0 [CI, 1.6 to 9.8]; P = 0.002), decubitus ulcer (odds ratio, 4.0 [CI, 1.6 to 9.8]; P = 0.002), and neurogenic bladder (odds ratio, 4.6 [CI, 1.4 to 15.1]; P = 0.01). Sixty-three percent of community case-patients had at least one of these conditions. Nosocomial infection (48 cases [22%]) was independently associated with the placement of a central venous line (odds ratio, 30.9 [CI, 5.2 to 184.1]; P < 0.001), diabetes, congestive heart failure, and seizure disorder.

Conclusions: Several chronic conditions were independently associated with group B streptococcal disease, and most case-patients had at least one of these conditions. If group B streptococcal vaccines being developed for prevention of neonatal disease are protective in adults, a vaccination strategy targeting those at highest risk has the potential to substantially reduce the burden of invasive group B streptococcal infection in adults.

Author and Article Information

From the Centers for Disease Control and Prevention and Emory University School of Medicine, Atlanta, Georgia; Johns Hopkins University, Baltimore, Maryland; and University of California at Berkeley, Berkeley, California.
Acknowledgments: The authors thank Ruth Bessinger, MPH, Lillian Bill-mann, RN, MPH, Matthew Brennan, MD, Pam Daily, MPH, Katherine A. Deaver-Robinson, Diane M. Dwyer, MD, R. Chris Harvey, MPH, Timm Missbach, MD, Bharat Pattni, MD, MPH, and Gretchen Rothrock, MPH, for their assistance in collecting the data for this study.
Requests for Reprints: Anne Schuchat, MD, Childhood and Respiratory Diseases Branch, Centers for Disease Control and Prevention, Mailstop C-09, Atlanta, GA 30333.
Current Author Addresses: Dr. Jackson: Department of Epidemiology, Box 357236 Seattle, WA 98195-7236.

This article has been cited by other articles:

				C. R. Phares, R. Lynfield, M. M. Farley, J. Mohle-Boetani, L. H. Harrison, S. Petit, A. S. Craig, W. Schaffner, S. M. Zansky, K. Gershman, et al. Epidemiology of Invasive Group B Streptococcal Disease in the United States, 1999-2005 JAMA, May 7, 2008; 299(17): 2056 - 2065. [Abstract] [Full Text] [PDF]

				G. R. Bolduc and L. C. Madoff The group B streptococcal alpha C protein binds {alpha}1 1-integrin through a novel KTD motif that promotes internalization of GBS within human epithelial cells Microbiology, December 1, 2007; 153(12): 4039 - 4049. [Abstract] [Full Text] [PDF]

				T. C. Auperin, G. R. Bolduc, M. J. Baron, A. Heroux, D. J. Filman, L. C. Madoff, and J. M. Hogle Crystal Structure of the N-terminal Domain of the Group B Streptococcus Alpha C Protein J. Biol. Chem., May 6, 2005; 280(18): 18245 - 18252. [Abstract] [Full Text] [PDF]

				L. Tissi, M. Puliti, F. Bistoni, P. Mosci, T. R. Kozel, and A. Vecchiarelli Glucuronoxylomannan, the Major Capsular Polysaccharide of Cryptococcus neoformans, Inhibits the Progression of Group B Streptococcal Arthritis Infect. Immun., November 1, 2004; 72(11): 6367 - 6372. [Abstract] [Full Text] [PDF]

				M. Puliti, C. von Hunolstein, F. Bistoni, G. Orefici, and L. Tissi Inhibition of Nitric Oxide Synthase Exacerbates Group B Streptococcus Sepsis and Arthritis in Mice Infect. Immun., August 1, 2004; 72(8): 4891 - 4894. [Abstract] [Full Text] [PDF]

				M. J. Baron, G. R. Bolduc, M. B. Goldberg, T. C. Auperin, and L. C. Madoff Alpha C Protein of Group B Streptococcus Binds Host Cell Surface Glycosaminoglycan and Enters Cells by an Actin-dependent Mechanism J. Biol. Chem., June 4, 2004; 279(23): 24714 - 24723. [Abstract] [Full Text] [PDF]

				M. Puliti, C. von Hunolstein, C. Verwaerde, F. Bistoni, G. Orefici, and L. Tissi Regulatory Role of Interleukin-10 in Experimental Group B Streptococcal Arthritis Infect. Immun., June 1, 2002; 70(6): 2862 - 2868. [Abstract] [Full Text] [PDF]

				M. Puliti, F. Bistoni, C. von Hunolstein, G. Orefici, and L. Tissi Severity of Group B Streptococcal Arthritis in Selected Strains of Laboratory Mice Infect. Immun., January 1, 2001; 69(1): 551 - 555. [Abstract] [Full Text] [PDF]

				J. F. Bohnsack, S. Takahashi, L. Hammitt, D. V. Miller, A. A. Aly, and E. E. Adderson Genetic Polymorphisms of Group B Streptococcus scpB Alter Functional Activity of a Cell-Associated Peptidase That Inactivates C5a Infect. Immun., September 1, 2000; 68(9): 5018 - 5025. [Abstract] [Full Text] [PDF]

				M. Sellin, C. Olofsson, S. Håkansson, and M. Norgren Genotyping of the Capsule Gene Cluster (cps) in Nontypeable Group B Streptococci Reveals Two Major cps Allelic Variants of Serotypes III and VII J. Clin. Microbiol., September 1, 2000; 38(9): 3420 - 3428. [Abstract] [Full Text]

				S. J. Schrag, S. Zywicki, M. M. Farley, A. L. Reingold, L. H. Harrison, L. B. Lefkowitz, J. L. Hadler, R. Danila, P. R. Cieslak, and A. Schuchat Group B Streptococcal Disease in the Era of Intrapartum Antibiotic Prophylaxis N. Engl. J. Med., January 6, 2000; 342(1): 15 - 20. [Abstract] [Full Text] [PDF]

				L. Tissi, M. Puliti, R. Barluzzi, G. Orefici, C. von Hunolstein, and F. Bistoni Role of Tumor Necrosis Factor Alpha, Interleukin-1beta , and Interleukin-6 in a Mouse Model of Group B Streptococcal Arthritis Infect. Immun., September 1, 1999; 67(9): 4545 - 4550. [Abstract] [Full Text] [PDF]

				M. A. Gardam, D. E. Low, R. Saginur, and M. A. Miller Group B Streptococcal Necrotizing Fasciitis and Streptococcal Toxic Shock-Like Syndrome in Adults Arch Intern Med, August 10, 1998; 158(15): 1704 - 1708. [Abstract] [Full Text]

				A. Schuchat Epidemiology of Group B Streptococcal Disease in the United States: Shifting Paradigms Clin. Microbiol. Rev., July 1, 1998; 11(3): 497 - 513. [Abstract] [Full Text] [PDF]

				Risk Factors for Adult Group B Strep Journal Watch Dermatology, October 1, 1995; 1995(1001): 17 - 17. [Full Text]

				RISK FACTORS FOR ADULT GROUP B STREP Journal Watch (General), September 19, 1995; 1995(919): 4 - 4. [Full Text]